Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (50%) |
| §103 only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHULTZHAUS, JANNA NICOLE | 1 | 36.0% | +35.7% |
| XU, XIAOYUN | 1 | 59.9% | +31.9% |
| SABOUR, GHAZAL | 1 | 34.3% | +38.5% |
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 30.4% | +49.0% |
| BEVERIDGE, CONNOR HAMMOND | 1 | 0.0% | +0.0% |
| JONES-FOSTER, ERICA NICOLE | 1 | 50.0% | +47.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18421663 | DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES | SCHULTZHAUS, JANNA NICOLE | 8d overdue |
| 18180789 | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING | XU, XIAOYUN | 28d |
| 17759714 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | SABOUR, GHAZAL | — |
| 17747851 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| 17688788 | BIOMARKERS FOR DETERMINING AN IMMUNO-ONCOLOGY RESPONSE | BEVERIDGE, CONNOR HAMMOND | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18421663 | DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES | SCHULTZHAUS, JANNA NICOLE | 8d overdue |
| 17433971 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | JONES-FOSTER, ERICA NICOLE | 1d overdue |
| 18180789 | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING | XU, XIAOYUN | 28d |
| 17759714 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | SABOUR, GHAZAL | — |
| 17747851 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| Art Unit | Apps |
|---|---|
| 1685 | 2 |
| 1797 | 1 |
| 1686 | 1 |
| 1687 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18421663 | DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES | SCHULTZHAUS, JANNA NICOLE | 1685 | §103§112Other | Final Rejection | 8d overdue | Pending | Jan 24, 2024 |
| 18180789 | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING | XU, XIAOYUN | 1797 | §102§103Other | Final Rejection | 28d | Pending | Mar 08, 2023 |
| 17759714 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | SABOUR, GHAZAL | 1686 | §101§103DP | Final Rejection | — | Pending | Jul 28, 2022 |
| 17747851 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112DP | Non-Final OA | — | Pending | May 18, 2022 |
| 17688788 | BIOMARKERS FOR DETERMINING AN IMMUNO-ONCOLOGY RESPONSE | BEVERIDGE, CONNOR HAMMOND | 1687 | §101§103§112 | Non-Final OA | — | Pending | Mar 07, 2022 |
| 17433971 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Final Rejection | 1d overdue | Pending | Aug 25, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial